Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years

Table 4

Overall complication probabilities for used ADMs.

ADM	HADM (Epiflex/DIZG), PADM (Strattice/LifeCell), BADM (Tutomesh/RTI Surgical)
Breasts (total)	52
Avg. follow-up time (in months)	36 (12–54)
Complications (total)	9 (17%)
Short-term complications
Skin necrosis	2 (4%)
Seroma	1 (2%)
Haematoma	0 (0%)
Infection	2 (4%)
	3
Long-term complications
Capsular	3 (6%)
Implant malposition	0 (0%)
Implant loss	1 (2%)

Short-term (skin necrosis, seroma, haematoma, infection, and Red Breast Syndrome (RBS)) and long-term complications (capsular contracture, implant malposition, and implant loss) for all breasts with usage of ADMs (human ADM (HADM), porcine ADM (PADM), bovine ADM (BADM)), median follow-up time for all patients, total complications of all breasts being reconstructed with ADMs; = excluded from overall complications, which required further medical treatment; = >Baker-St. II.